Skip to main contentSkip to navigation
Sirius Investors

AKAN Stock: Akanda Corp. Stock Price, Analysis & Insights

Get live AKAN stock price $13.40, comprehensive Akanda Corp. stock analysis, charts, news, and expert forecast. Real-time AKAN stock data and investment insights.

13.40
2.62%Today
AKANAkanda Corp. • NASDAQ Capital Market • Healthcare
Market Cap
433.70K
Volume
4.22K
52W High
209.23
52W Low
2.30

Loading chart data...

Akanda Corp. (AKAN) Overview

Akanda Corp. (AKAN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, AKAN trades at $13.40 with a market capitalization of 433.70K . Over the past 52 weeks, AKAN has traded between $2.30 and $209.23 , with the current price positioned at approximately 5% of this range . The stock...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 433.70K
  • Current price: $13.40
  • 52-week range: $2.30 - $209.23
  • P/E ratio: 0.02

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim t...

Company Information

CEO
Katharyn Field
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
46

Contact Information

Address
1a, 1b Learoyd Road
Country
GB

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 0.0)

Higher growth potential with elevated volatility (Beta: 1.73)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Akanda Corp. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Akanda Corp.
  • Investors should consider how Akanda Corp. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

433.70K

P/E Ratio (TTM)

0.02

Beta

1.73

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.